Not recommended Not recommended

Recom mended

Recommended

Recommended

recommended

Recom mended

Deprecated.

4.8.2009 EN

Not Recommended

Periodic visual examinations during IntronA therapy are recommended particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.

If a dose adjustment is required to maintain haemoglobin at the desired level, it is recommended that the dose is adjusted by approximately 25 .

should be used.

If these medicinal products are co administered, careful monitoring of full blood counts and adverse events related to increased rifabutin levels (e. g. uveitis) is recommended.

Periodic visual examinations are recommended during PegIntron therapy, particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.

Periodic visual examinations are recommended during Peg Intron therapy, particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.

4.7

Stalevo is not recommended for the treatment of drug induced extrapyramidal reactions

Not recommended

Careful monitoring of full blood counts and adverse events to rifabutin (e. g. uveitis) is recommended when rifabutin is coadministered with voriconazole.

Careful monitoring of full blood counts and adverse reactions to rifabutin (e. g. uveitis) is recommended when rifabutin is coadministered with voriconazole.

not recommended.

Periodic visual examinations during Viraferon therapy are recommended particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.

Periodic visual examinations are recommended during ViraferonPeg therapy, particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension.

For this reason, and to reduce the risk of HIV transmission, barrier contraception (e. g., condoms) is recommended.

For this reason, and to reduce the risk of HIV transmission, barrier contraception (e. g. condoms) is recommended.

Recommended Revaluation suspense accounts Mandatory

Recommended UTF 8

Emadine is not recommended for patients older than 65 years or in patients who have problems with their liver or kidneys.

Since lamivudine and the virus pass into breast milk, it is recommended that mothers taking Epivir do not breast feed their infants.

ed is not recommended if you have breathing difficulties with congestive heart failure.

Once adequate control of symptoms is achieved, dose reduction to one spray actuation in each nostril once daily (total daily dose, 55 micrograms) is recommended.

726 2004.

If a dose adjustment is required to maintain haemoglobin at the desired level, it is recommended that the dose is adjusted by approximately 25 . du

approximately 25 , depending on the rate of increase.

37 treatment and close observation of the patient are recommended in cases of overdose.

60 treatment and close observation of the patient are recommended in cases of overdose.

83 treatment and close observation of the patient are recommended in cases of overdose.

106 treatment and close observation of the patient are recommended in cases of overdose.

Liver function tests are recommended before initiation, every 6 to 12 weeks for the first year, and periodically (e. g. semi annually) thereafter.

The CHMP has recommended the variation of the Marketing Authorisations for PROCOMVAX in accordance with Article 5(2) of Regulation (EC) No 726 2004.

After reconstitution, the vaccine should be injected promptly.

Co administration of diltiazem and REYATAZ ritonavir has not been studied.

needed and ECG monitoring.

Other psychiatric conditions Therapy with rimonabant is not recommended in patients with uncontrolled psychiatric illness. d

Reversible, selective MAO A inhibitor (moclobemide) Due to the risk of serotonin syndrome, the combination of venlafaxine with a reversible and selective MAOI, such as moclobemide, is not recommended.